Diseases (Basel, Switzerland)
Real-World Evidence Evaluation of Respiratory Syncytial Virus (RSV) Vaccines: Deep Dive into Vaccine Adverse Events Reporting System.
Thamir M Alshammari, Mohammed K Alshammari, Hind M Alosaimi
Published: 202610.3390/diseases14010029
Abstract
Background: Respiratory Syncytial Virus is a predominant source of morbidity and mortality, particularly among babies, the elderly, and immunocompromised patients. Recent developments in RSV vaccines, approved by the FDA for high-risk groups, have hi…
Preview only. Read the full abstract at the source